HE3235

· Harbor Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HE3235, covering 2011-03-09 to 2011-03-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Study of HE3235 in Patients With Prostate Cancer [Phase 1, Phase 2]